Elecsys Anti-SARS-CoV-2— 510(k) K250768
Substantially EquivalentRoche Diagnostics
FDA 510(k) clearance K250768 for Elecsys Anti-SARS-CoV-2, Substantially Equivalent on 2025-06-10. Applicant: Roche Diagnostics.
Clearance details
- Applicant
- Roche Diagnostics
- Product code
- Code QVP
- Advisory panel
- Microbiology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Indianapolis, IN, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.